These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3056674)
1. Selective inhibition of thromboxane synthetase reduces group-B-beta-hemolytic-streptococci-induced pulmonary hypertension in piglets. Hammerman C; Komar K; Meadow W; Strates E Dev Pharmacol Ther; 1988; 11(5):306-12. PubMed ID: 3056674 [TBL] [Abstract][Full Text] [Related]
2. Thromboxane synthesis inhibition reverses group B Streptococcus-induced pulmonary hypertension. Tarpey MN; Graybar GB; Lyrene RK; Godoy G; Oliver J; Gray BM; Philips JB Crit Care Med; 1987 Jul; 15(7):644-7. PubMed ID: 3297489 [TBL] [Abstract][Full Text] [Related]
3. Thromboxane-associated pulmonary hypertension during three types of gram-positive bacteremia in piglets. Gibson RL; Truog WE; Redding GJ Pediatr Res; 1988 Jun; 23(6):553-6. PubMed ID: 3134642 [TBL] [Abstract][Full Text] [Related]
4. Neonatal group B streptococcal sepsis: effects of late treatment with dazmegrel. Truog WE; Gibson RL; Juul SE; Henderson WR; Redding GJ Pediatr Res; 1988 Apr; 23(4):352-6. PubMed ID: 3287320 [TBL] [Abstract][Full Text] [Related]
5. Lipoxygenase and cyclooxygenase blockade by BW755C does not prevent the secondary phase of septic pulmonary hypertension. Hammerman C; Aramburo MJ; Hill V Prostaglandins Leukot Essent Fatty Acids; 1989 Aug; 37(2):71-7. PubMed ID: 2506581 [TBL] [Abstract][Full Text] [Related]
6. Effects of the thromboxane synthetase inhibitor, dazmegrel (UK 38,485), on pulmonary gas exchange and hemodynamics in neonatal sepsis. Truog WE; Sorensen GK; Standaert TA; Redding GJ Pediatr Res; 1986 May; 20(5):481-6. PubMed ID: 3520468 [TBL] [Abstract][Full Text] [Related]
7. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor. Carter AJ; Bevan JA; Hanley SP; Morgan WE; Turner DR Thromb Haemost; 1984 Apr; 51(2):257-60. PubMed ID: 6377567 [TBL] [Abstract][Full Text] [Related]
8. Delayed thromboxane synthesis inhibition, but not cholinergic blockade, reverses group B streptococcus-induced pulmonary hypertension. Li JX; Gray BM; Oliver JR; Lu CY; Philips JB Dev Pharmacol Ther; 1992; 19(1):40-9. PubMed ID: 1307345 [TBL] [Abstract][Full Text] [Related]
9. Capsular type-specific polysaccharide partially inhibits group B Streptococcus-induced pulmonary hypertension. Li JX; Gray BM; Pritchard DG; Oliver JR; Grantham KD; Philips JB Am Rev Respir Dis; 1993 Jul; 148(1):152-7. PubMed ID: 8317791 [TBL] [Abstract][Full Text] [Related]
10. Delayed thromboxane or tumor necrosis factor-alpha, but not leukotriene inhibition, attenuates prolonged pulmonary hypertension in endotoxemia. Li JX; Oliver JR; Lu CY; Philips JB Am J Med Sci; 1995 Sep; 310(3):103-10. PubMed ID: 7668305 [TBL] [Abstract][Full Text] [Related]
11. Effects of hyperventilation on prostacyclin formation and on pulmonary vasodilation after group B beta-hemolytic streptococci-induced pulmonary hypertension. Hammerman C; Aramburo MJ Pediatr Res; 1991 Mar; 29(3):282-7. PubMed ID: 2034476 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E1 selectively reduces group B beta-hemolytic streptococci-induced pulmonary hypertension in newborn piglets. Hammerman C; Aramburo MJ; Choi JH Am J Dis Child; 1989 Mar; 143(3):343-7. PubMed ID: 2492755 [TBL] [Abstract][Full Text] [Related]
13. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. Casey LC; Fletcher JR; Zmudka MI; Ramwell PW J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528 [TBL] [Abstract][Full Text] [Related]
14. Thromboxane and pulmonary morphometry in the development of the pulmonary hypertensive response to group B streptococcus. Barefield ES; Hicks TP; Philips JB Crit Care Med; 1994 Mar; 22(3):506-14. PubMed ID: 8125003 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular changes in group B streptococcal sepsis in the piglet: response to indomethacin and relationship to prostacyclin and thromboxane A2. Runkle B; Goldberg RN; Streitfeld MM; Clark MR; Buron E; Setzer ES; Bancalari E Pediatr Res; 1984 Sep; 18(9):874-8. PubMed ID: 6384909 [TBL] [Abstract][Full Text] [Related]
16. Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative. Watkins WD; Hüttemeier PC; Kong D; Peterson MB Prostaglandins; 1982 Mar; 23(3):273-85. PubMed ID: 7048422 [TBL] [Abstract][Full Text] [Related]
17. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses. Hardee MM; Moore JN; Hardee GE Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032 [TBL] [Abstract][Full Text] [Related]
19. Isogenic group B streptococci devoid of capsular polysaccharide or beta-hemolysin: pulmonary hemodynamic and gas exchange effects during bacteremia in piglets. Gibson RL; Redding GJ; Truog WE; Henderson WR; Rubens CE Pediatr Res; 1989 Sep; 26(3):241-5. PubMed ID: 2685736 [TBL] [Abstract][Full Text] [Related]
20. Effect of amrinone during group B Streptococcus-induced pulmonary hypertension in piglets. Berger JI; Gibson RL; Clarke WR; Standaert TA; Redding GJ; Henderson WR; Truog WE Pediatr Pulmonol; 1993 Nov; 16(5):303-10. PubMed ID: 8255635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]